TTNP icon

Titan Pharmaceuticals
TTNP

Overview Fund Activity

14 hedge funds and large institutions have $9.41K invested in Titan Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Osaic Holdings
1
Osaic Holdings
Arizona
$47
2
SS
2
SBI Securities
Japan
$3

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
UBS Group
2
UBS Group
Switzerland
$8.69K
3
TRCT
3
Tower Research Capital (TRC)
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$10
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
1
UBS Group
Switzerland
$8.69K 2,667 -2,106 -44%
MA
2
MCF Advisors
Kentucky
$538 165 – –
Bank of America
3
Bank of America
North Carolina
$55 17 – –
Osaic Holdings
4
Osaic Holdings
Arizona
$47 15 +5 +50%
Group One Trading
5
Group One Trading
Illinois
$39 12 – –
Morgan Stanley
6
Morgan Stanley
New York
$10 3 -1 -25%
GWSA
7
Global Wealth Strategies & Associates
Colorado
$7 2 – –
WIM
8
Westside Investment Management
California
$3 1 – –
CSC
9
Caldwell Sutter Capital
California
$3 1 – –
DJSG
10
D.J. St. Germain
Massachusetts
$3 1 – –
CIA
11
Cape Investment Advisory
Georgia
$3 1 – –
Wells Fargo
12
Wells Fargo
California
$3 1 – –
NRG
13
Nemes Rush Group
Michigan
$3 1 – –
SS
14
SBI Securities
Japan
$3 1 +1 New
Renaissance Technologies
15
Renaissance Technologies
New York
– – -11,066 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– – -743 Closed
CFGS
17
Concourse Financial Group Securities
Alabama
– – – –